JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Bradley S. Allen
Renee S. Hartz
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolling, K.
Right arrow Articles by Feinberg, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolling, K.
Right arrow Articles by Feinberg, H.

J Thorac Cardiovasc Surg 1996;112:1193-1201
© 1996 Mosby, Inc.


SURGERY FOR CONGENITAL HEART DISEASE

MYOCARDIAL PROTECTION IN NORMAL AND HYPOXICALLY STRESSED NEONATAL HEARTS: THE SUPERIORITY OF HYPOCALCEMIC VERSUS NORMOCALCEMIC BLOOD CARDIOPLEGIA

Kirk Bolling, MD, Michael Kronon, MD*, Bradley S. Allen, MD, Shaik Ramon, MS, Tingrong Wang, MD, Renee S. Hartz, MD, Harold Feinberg, PhD

From the Division of Cardiothoracic Surgery, University of Illinois, Chicago, Ill.

Received for publication April 30, 1996 Revisions requested May 30, 1996; revisions received July 15, 1996 Accepted for publication July 17, 1996. Address for reprints: Bradley S. Allen, MD, University of Illinois, Cardiothoracic Surgery Department, 840 S. Wood Street, 515 CSN (M/C 958), Chicago, IL 60612.

Abstract

Objectives:The ideal cardioplegic calcium (Ca+2) concentration in newborns continues to be debated. Most studies examining cardioplegia calcium concentrations have been done with a nonclinical model (i.e., isolated heart preparation), the results of which may not be clinically applicable, and they have not examined the effect of calcium concentration in a clinically relevant stressed (hypoxic) heart. Methods:Twenty neonatal piglets 5 to 18 days old were placed on cardiopulmonary bypass, and their aortas were crossclamped for 70 minutes with hypocalcemic or normocalcemic multidose blood cardioplegic infusions. Group 1 (n= 5; low Ca+2, 0.2 to 0.4 mmol/L) and group 2 (n= 5; normal Ca+2, 1.0 to 1.3 mmol/L) were nonhypoxic (uninjured) hearts. Ten other piglets were first ventilated at an Fio2of 8% to 10% (O2saturation 65% to 70%) for 60 minutes (i.e., causing hypoxia) and then reoxygenated at an Fio2of 100% with cardiopulmonary bypass, which produces a clinically relevant stress injury. They then underwent cardioplegic arrest (as described above) with a hypocalcemic (n= 5, group 3) or normocalcemic (n= 5, group 4) blood cardioplegic solution. Myocardial function was assessed with pressure volume loops and expressed as a percentage of control values. Coronary vascular resistance was measured during each cardioplegic infusion. All values were reported as the mean ± standard error. Results:In nonhypoxic hearts (groups 1 and 2), good myocardial protection was achieved at either concentration of cardioplegia calcium, as demonstrated by preservation of postbypass systolic function (104% vs 99% end-systolic elastance), minimally increased diastolic stiffness (152% vs 162%), no difference in myocardial water (78.9% vs 78.9%), and no change in adenosine triphosphate levels or coronary vascular resistance. Low-calcium blood cardioplegia solution repaired the hypoxic reoxygenation injury in stressed hearts (group 3), resulting in no statistical difference in myocardial function, coronary vascular resistance, or adenosine triphosphate levels compared with nonhypoxic hearts (groups 1 and 2). Conversely, when a normocalcemic cardioplegia solution was used in hypoxic hearts (group 4), there was marked reduction in postbypass systolic function (49% ± 4% end-systolic elastance; p< 0.05), increased diastolic stiffness (276% ± 9%; p< 0.05), increased myocardial water (80.1% ± 0.2%; p< 0.05), rise in coronary vascular resistance (p< 0.05), and lower adenosine triphosphate levels compared with groups 1, 2, and 3. Conclusions:This study demonstrates that, in the clinically relevant, intact animal model, good myocardial protection is independent of cardioplegia calcium concentration in nonhypoxic (noninjured) hearts; hypoxic (stressed) hearts are extremely sensitive to the cardioplegic calcium concentration; and normocalcemic cardioplegia is detrimental to neonatal myocardium subjected to a preoperative hypoxic stress. (J THORAC CARDIOVASC SURG 1996;112:1193-201)




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
J. D. O'Brien, S. E. Howlett, H. J. Burton, S. B. O'Blenes, D. S. Litz, and C. L. H. Friesen
Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin T.
Ann. Thorac. Surg., May 1, 2009; 87(5): 1517 - 1523.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Modi and M. S. Suleiman
Invited commentary.
Ann. Thorac. Surg., May 1, 2009; 87(5): 1523 - 1524.
[Full Text] [PDF]


Home page
MMCTSHome page
C. Schlensak
Myocardial protection in congenital heart surgery
MMCTS, November 29, 2005; 2005(1129): 729.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. S. Allen
Fetal cardiac surgery: Simplicity versus success in a new frontier
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1254 - 1256.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. P. Malhotra, S. Thelitz, R. K. Riemer, V. M. Reddy, S. Suleman, and F. L. Hanley
Fetal myocardial protection is markedly improved by reduced cardioplegic calcium content
Ann. Thorac. Surg., June 1, 2003; 75(6): 1937 - 1941.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Doenst, C. Schlensak, and F. Beyersdorf
Cardioplegia in pediatric cardiac surgery: do we believe in magic?
Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. S. Allen, J. S. Veluz, G. D. Buckberg, E. Aeberhard, and L. J. Ignarro
Deep hypothermic circulatory arrest and global reperfusion injury: Avoidance by making a pump prime reperfusate--A new concept
J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 625 - 632.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, M. J. Barth, and M. Ilbawi
Delivery of a nonpotassium modified maintenance solution to enhance myocardial protection in stressed neonatal hearts: A new approach
J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 119 - 129.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
B. S Allen and M. N Ilbawi
Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery
Perfusion, January 1, 2001; 16(1_suppl): 19 - 29.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. T. Kronon, B. S. Allen, K. S. Bolling, S. Rahman, T. Wang, H. S. Maniar, S. M. Prasad, and M. N. Ilbawi
The role of cardioplegia induction temperature and amino acid enrichment in neonatal myocardial protection
Ann. Thorac. Surg., September 1, 2000; 70(3): 756 - 764.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. T. Kronon, B. S. Allen, J. Hernan, A. O. Halldorsson, S. Rahman, G. D. Buckberg, T. Wang, and M. N. Ilbawi
Superiority of magnesium cardioplegia in neonatal myocardial protection
Ann. Thorac. Surg., December 1, 1999; 68(6): 2285 - 2291.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, T. Wang, and M. Ilbawi
DOSE DEPENDENCY OF L-ARGININE IN NEONATAL MYOCARDIAL PROTECTION: THE NITRIC OXIDE PARADOX
J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 655 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, T. Wang, and M. Ilbawi
L-ARGININE, PROSTAGLANDIN, AND WHITE CELL FILTRATION EQUALLY IMPROVE MYOCARDIAL PROTECTION IN STRESSED NEONATAL HEARTS
J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 665 - 673.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Kronon, K. S. Bolling, B. S. Allen, A. O. Halldorsson, T. Wang, and S. Rahman
The importance of cardioplegic infusion pressure in neonatal myocardial protection
Ann. Thorac. Surg., October 1, 1998; 66(4): 1358 - 1364.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. N. Young, I. O. Choy, N. K. Silva, D. Y. Obayashi, and H. E. Barkan
ANTEGRADE COLD BLOOD CARDIOPLEGIA IS NOT DEMONSTRABLY ADVANTAGEOUS OVER COLD CRYSTALLOID CARDIOPLEGIA IN SURGERY FOR CONGENITAL HEART DISEASE
J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 1002 - 1009.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Kronon, K. S. Bolling, B. S. Allen, S. Rahman, T. Wang, A. Halldorsson, and H. Feinberg
THE RELATIONSHIP BETWEEN CALCIUM AND MAGNESIUM IN PEDIATRIC MYOCARDIAL PROTECTION
J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 1010 - 1019.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
B. S. Allen, S. Rahman, M. N. Ilbawi, M. Kronon, K. S. Bolling, A. O. Halldorsson, and H. Feinberg
Detrimental Effects of Cardiopulmonary Bypass in Cyanotic Infants: Preventing the Reoxygenation Injury
Ann. Thorac. Surg., November 1, 1997; 64(5): 1381 - 1388.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. E. Baker and G. N. Olinger
Myocardial protection of the hypoxic heart
J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1123 - 1124.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The American Association for Thoracic Surgery.